Table 3

Generic and disease-specific quality of life and symptom severity according to PTS development

PTS (n=92)No PTS (n=97)Mean differencep Value*
24 months
 Generic QOLEQ-5D0.77 (0.730 to 0.819)0.86 (0.823 to 0.903)0.09 (0.03 to 0.15)<0.001
 Disease-specific QOLVEINES-QOL45.6 (43.4 to 47.9)54.2 (52.8 to 55.6)8.6 (5.9 to 11.2)<0.001
VEINES-Sym45.0 (42.7 to 47.2)54.8 (53.5 to 56.0)9.8 (7.3 to 12.3)<0.001
6 months
 Generic QOLEQ-5D0.80 (0.770 to 0.837)0.82 (0.788 to 0.869)0.02 (−0.08 to 0.28)0.062
 Disease-specific QOLVEINES-QOL46.8 (44.6 to 49.0)53.0 (51.3 to 54.7)6.2 (3.4 to 9.09)<0.001
VEINES-Sym46.9 (44.6 to 49.1)53.0 (51.4 to 54.6)6.1 (3.4 to 8.9)<0.001
  • Data are mean values (95% CI).

  • *Mann Whitney U test.

  • PTS, post-thrombotic syndrome; QOL, quality of life.